Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
Novo pads case for Wegovy in a pill ahead of FDA decision
The latest data on Novo's Wegovy in a pill come at a crucial time, given Lilly’s data drop on its own oral weight loss candidate earlier this week.
Fraiser Kansteiner
Sep 18, 2025 9:59am
Novo charts major restructuring, layoffs under new CEO
Sep 10, 2025 8:41am
Novo, Lilly obesity meds 'highly cost-effective': ICER report
Sep 9, 2025 10:30am
Wegovy tops Zepbound on CV risk reduction in real-world study
Sep 2, 2025 11:33am
Lilly pauses UK orders on its diabetes and obesity med Mounjaro
Aug 28, 2025 11:08am
Fierce Biotech
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
